Early Access — free while we kick the tires
EdgarHawk

Veinstein Bar

President, A&G

Officer
2 filings analyzed · 1 company · Latest 2025-12-02

Companies

Company Buys Sells Direction
CLARIVATE PLC CLVT 0 2 Net selling

Activity

December 2025
2025-12-02 CLARIVATE PLC CLVT
high
Sell
309,902 shares
$1,159,033
Significance 5/10

President of A&G Veinstein Bar sold 309,902 shares of CLVT at $3.74 on 2025-12-01; stock now $3.68, -36.8% from 52-week high.

Veinstein Bar, President of A&G at Clarivate, sold 309,902 shares valued at $1,159,033.48, reducing holdings by 26.7% to 848,811 shares. The sale occurred at $3.74, and the stock has since declined to $3.68, sitting -36.8% below its 52-week high of $5.82. His cross-ticker track record shows a 100.00% well-timed rate on 1 prior sell, and at CLVT specifically, he executed a prior sale on 2024-09-19 that delivered -28.6% over 90 days, demonstrating consistent downside capture timing. Set against Clarivate's deteriorating fundamentals—net income of $-28,300,000.00 on revenue of $623,100,000.00, negative annual revenue growth of -2.7%, and ongoing unprofitability—this large, discretionary reduction of holdings aligns with his historical pattern of selling ahead of weakness and underscores the company's challenged financial position.

September 2024
2024-09-23 CLARIVATE PLC CLVT
medium
Sell
120,000 shares
$840,000
Significance 5/10

Clarivate President Veinstein Bar sold 120.0K shares at $7.00; stock now -28.2% from 52-week high amid ongoing losses.

Veinstein Bar, President of A&G, sold 120,000 shares on 2024-09-19 at $7.00 per share, reducing his holdings by -10.9% from 1.10M to 976.6K shares. The sale occurred at a price notably above the current $6.78 price but well below the 52-week high of $9.44, with the stock currently trading -28.2% from that peak. Clarivate remains unprofitable, posting a net loss of $-304.3M on quarterly revenue of $650.3M, and has contracted annually by -1.2%, creating a backdrop of operational strain. The sale by a senior executive occurs in a context where the company has materially deteriorated from recent highs, though the 30-day and 90-day price action show recent recovery (+2.0% and +19.6% respectively).

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access